Recon: Prasad returns FDA as CBER chief; FDA grants priority review for GSK’s gonorrhea antibiotic
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesReconJason ScottBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States